FDA rejects injectable Zyprexa – Regulators seek more data after some side effects seen in testing

Indianapolis Star
By John Russell
Eli Lilly and Co. has hit a roadblock in its efforts to extend the life of its top-selling product, the schizophrenia drug Zyprexa, which loses its patent protection against generic rivals in three years.
The Food and Drug Administration rejected Lilly’s application to sell a once-a-month injectable version of Zyprexa, the Indianapolis drug [...]

Lilly Prepares for Zyprexa Case

Associated Press
NEW YORK (Associated Press) – Eli Lilly and Co. finally heads to court next week to fight the long-standing accusation that it failed to warn doctors and patients about complications tied to its top-selling drug Zyprexa.
Lilly will face the state of Alaska in a trial in Anchorage that centers on Medicaid patients who use [...]